Skip to content
Trial Eligibility
Menu

Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin Levels

NCT05349292

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Acute normovolemic hemodilution (ANH) is performed as a blood conservation technique during surgical procedures with high risk for significant blood loss. It is done by taking out some of the patients blood before surgery actually begins and storing this blood inside of the operating room and giving it back to the patient at the end of surgery when most of the expected surgical bleeding has already occurred. This practice reduces the amount of bleeding that occurs after surgery and also reduces the amount of blood transfusions given to the patient after surgery.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Acute Kidney Injury

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 70 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Maryland, Baltimore
Last updated on ClinicalTrials.gov
May 1, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • University of Maryland Medical Center · Baltimore, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.